Flumazenil to reverse remimazolam after kidney transplant
Part of Kidney & urinary clinical trials.
This study tests if flumazenil can safely and quickly reverse the effects of remimazolam (a sedative) after kidney transplant surgery. It may help patients wake up faster from anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 64 years old.
- You are scheduled for a planned (non-emergency) kidney transplant.
- You are not allergic to narcotic pain medicines or sedatives.
- You have not had liver failure or a liver transplant.
- You have not had general anesthesia in the last 30 days or plan to have it again in the next 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a sedative called remimazolam works well and safely for people getting a kidney transplant. It might help you stay calm and comfortable during surgery.
This study tests whether a sedation drug called remimazolam can help protect your kidneys during liver or pancreas surgery. If you are having one of these surgeries, you might be able to join.
This trial tests if giving flumazenil after remimazolam sedation can help people think more clearly after hip replacement surgery. If you are having a planned hip replacement and are generally healthy, this study might be for you.
This study looks at whether a medicine called flumazenil can help people wake up more safely and recover better after being put to sleep for hip surgery using a specific anesthesia medication. It may help doctors understand the best way to reverse anesthesia effects in older adults.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
Hear when a new Remimazolam trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.